Http://www.intensive.org/admin/pre_printsessionpdf.asp

Opening [Standard presentation]
A look back at our past
Jean-Louis Vincent (Brussels , Belgium)
Report of the Round Table conference on “Evidence in the ICU”
John J Marini (St Paul , United States) - Djillali Annane (Garches , France)
EGDT ProCESS?
Derek C Angus (Pittsburgh , United States)
Immunotherapy of Sepsis - the New Frontier
Richard Hotchkiss (St Louis , United States)
Big data [Standard presentation]
Data mining with MIMIC
Leo Anthony Celi (Cambridge, United States)
Merging genetic with clinical data
Jean-Paul Mira (Paris , France)
eRecords for benchmarking and performance assessment
Theodore J Iwashyna (Ann Arbor, United States)
eResearch: Why it's not just fancy chart review
John Kellum (Pittsburgh , United States)
Big international consortia
John C Marshall (Toronto , Canada)
The experience of the Surviving Sepsis Campaign
Mitchell Levy (Providence , United States)
Government use of electronic data
Jeremy M Kahn (Pittsburgh , United States)
Understanding sepsis [Standard presentation]
Interactions between bacteria and other pathogens
Philippe Montravers (Paris , France)
Receptor signaling in the pathogenesis of sepsis
Tom van der Poll (Amsterdam , Netherlands)
Mechanisms of cell death in sepsis
Richard Hotchkiss (St Louis , United States)
Apoptosis
John C Marshall (Toronto , Canada)
Autophagy
Greet Van Den Berghe (Leuven , Belgium)
Stressful encounters
Mervyn Singer (London , United Kingdom)
Role of the inflammasome
Thierry Calandra (Lausanne , Switzerland)
Immunoparalysis
Peter Pickkers (Nijmegen , Netherlands)
Neurophysiologic bases [Standard presentation]
Cerebral metabolism
Mauro Oddo (Lausanne , Switzerland)
Intracerebral mechanics
Marek Mirski (Baltimore , United States)
Cerebral perfusion
Giuseppe Citerio (Monza , Italy)
Electrical activity of the brain
Marek Mirski (Baltimore , United States)
Regional circulation [Standard presentation]
In the brain
Nino Stocchetti (Milan , Italy)
In the lung
Paolo Pelosi (Genoa , Italy)
In the kidney
Rinaldo Bellomo (Melbourne, Australia)
In the GI tract
Jukka Takala (Bern , Switzerland)
In the muscle and skin
Jan Bakker (Rotterdam , Netherlands)
Respiratory failure: Pathophysiological aspects [Standard presentation]
Control of breathing during mechanical ventilation
Dimitris Georgopoulos (Heraklion , Greece)
How I distinguish hydrostatic and increased permeability pulmonary edema
Jean-Louis Teboul (Le Kremlin-Bicêtre , France)
Gas exchange in ARDS
Antonio Pesenti (Milan , Italy)
Peripheral airways and hyperinflation
Christian Karagiannidis (Köln, Germany)
Mechanical interdependence of the chest wall and abdomen
John J Marini (St Paul , United States)
The kidney in respiratory failure
Michael Darmon (Saint-Priest-en-Jarez, France)
Fluid in the wrong place [Standard presentation]
Role of the glycocalyx
Can Ince (Amsterdam , Netherlands)
Managing by echo
Paul H Mayo (New York , United States)
Pleural effusion and chest wall behavior
Luciano Gattinoni (Milan , Italy)
Tap it or ignore it?
John J Marini (St Paul , United States)
What to do with ascites?
Pere Ginès (Barcelona, Spain)
Have me made progress? [Standard presentation]
In sepsis
Rinaldo Bellomo (Melbourne, Australia)
In renal failure
Giovanni Landoni (Milan, Italy)
In pediatric critical care
Niranjan (Tex) Kissoon (Vancouver , Canada)
In ARDS
Arthur S Slutsky (Toronto , Canada)
Beta-blockade for everyone? [Standard presentation]
In the perioperative patient
Stefan De Hert (Ghent , Belgium)
In the cirrhotic patient
Thomas Sersté (Bruxelles, Belgium)
In the neurosurgical patient
Peter Le Roux (Wynnewood, United States)
In the cardiovascular patient
Antonio Messias (Loures, Portugal)
In the septic patient
Bruno Levy (Vandoeuvre Les Nancy , France)
Clinical studies in septic shock
Andrea Morelli (Rome , Italy)
Empiric antimicrobial therapy [Standard presentation]
Empiric therapy
Marin Kollef (St Louis , United States)
Mono- or biotherapy
Thierry Calandra (Lausanne , Switzerland)
Therapy of severe CAP
Michael S Niederman (Mineola , United States)
The special case of pneumococcal CAP
Jean-Paul Mira (Paris , France)
Therapy of VAP
Richard Wunderink (Chicago , United States)
Should patients with septic shock be treated empirically with antifungals?
Markus Ruhnke (Berlin , Germany)
Target blood pressure [Standard presentation]
MAP: The higher the better in septic shock?
Claude Martin (Marseille , France)
How to run the circulation at the lowest possible pressures
Jan Bakker (Rotterdam , Netherlands)
Consider the MAP gap
Rinaldo Bellomo (Melbourne, Australia)
Does one blood pressure target fit all?
Peter Radermacher (Ulm , Germany)
Optimal pressure for the body's organs
Michael Pinsky (Pittsburgh , United States)
Renal failure in cirrhosis: Vasopressin or norepinephrine?
Paolo Angeli (Padova , Italy)
A pragmatic approach to optimize blood pressure
Stephen Trzeciak (Camden , United States)
Another look a vasopressors [Standard presentation]
Myocardial effects of vasopressors
Bruno Levy (Vandoeuvre Les Nancy , France)
Hemodynamic effects of norepinephrine revisited
Xavier Monnet (Le Kremlin-Bicêtre , France)
Anything new about vasopressin?
Daniel De Backer (Brussels , Belgium)
A place for angiotensin II?
Lakhmir Chawla (Washington , United States)
Blood lactate in 2014 [Standard presentation]
A review of its metabolism in shock states
Bruno Levy (Vandoeuvre Les Nancy , France)
Lactate has a beneficial role
Antonio Pesenti (Milan , Italy)
Time course of lactate in hemorrhagic shock
Paul E Pepe (Dallas , United States)
Time course of lactate in septic shock
Jan Bakker (Rotterdam , Netherlands)
Blood lactate as a resuscitation target
Gernot Marx (Aachen , Germany)
Intraabdominal hypertension [Standard presentation]
How to measure and improve abdominal wall compliance
Manu Malbrain (Antwerp , Belgium)
Prevention is the key
Jan De Waele (Ghent , Belgium)
Higher tidal volume and lower PEEP?
Paolo Pelosi (Genoa , Italy)
Higher PEEP and lower tidal volume?
Arthur S Slutsky (Toronto , Canada)
Adjunct therapies in sepsis [Standard presentation]
Should fever be treated?
Paul Young (Wellington, New Zealand)
Immunoglobulins
Axel Nierhaus (Hamburg , Germany)
IgM with IgG?
Figen Esen (Istanbul , Turkey)
Statins
Laurent Papazian (Marseille , France)
Beta-blockade
Djillali Annane (Garches , France)
Levosimendan is my favorite drug
Andrea Morelli (Rome , Italy)
Antithrombin
Christian J Wiedermann (Bolzano , Italy)
Corticosteroids in 2014 [Standard presentation]
The HPA axis is suppressed during critical illness
Djillali Annane (Garches , France)
The HPA axis is not suppressed during critical illness
Greet Van Den Berghe (Leuven , Belgium)
The problem is in the cell
Clifford S Deutschman (Philadelphia , United States)
Steroids in sepsis: do we need another trial?
Balasubramanian Venkatesh (Brisbane , Australia)
In ARDS?
Djillali Annane (Garches , France)
In severe CAP?
Antoni Torres (Barcelona , Spain)
In trauma?
Jacques Duranteau (Le Kremlin-Bicêtre , France)
Biomarkers in sepsis and ARDS [Standard presentation]
Genome wide associated studies to define targets
Didier Payen (Paris , France)
Biomarkers in ARDS
Arthur S Slutsky (Toronto , Canada)
Biomarker discovery through proteomics
Jean-Daniel Chiche (Paris , France)
Biomarker discovery through metabolomics
Greg S Martin (Atlanta , United States)
Monitoring the immune system in sepsis
Anthony McLean (Sydney , Australia)
The utility of procalcitonin in critically ill septic patients
Yahya Shehabi (Randwick, Australia)
Procalcitonin to identify infection in heart failure
Martin Möckel (Berlin, Germany)
I am not sure PCT is sohelpful
Mervyn Singer (London , United Kingdom)
Alternative biomarkers
Tommaso Mauri (Monza , Italy)
Patient-ventilator dysynchrony [Standard presentation]
Mechanisms
Dimitris Georgopoulos (Heraklion , Greece)
Recognition
Marco Ranieri (Turin , Italy)
We should mesure intratracheal pressure-swings
Diederik Gommers (Rotterdam , Netherlands)
It is harmful
Robert M Kacmarek (Boston , United States)
… maybe beneficial ?
Laurent Brochard (Toronto, Canada)
Managing the respirator
Neil R MacIntyre (Durham , United States)
Managing the patient
Paolo Navalesi (Novara , Italy)
Aim before you act: Defining a rational basis for selecting a ventilatory mode
Robert Chatburn (Cleveland, United States)
Partial ventilatory support [Standard presentation]
Where are we now?
Niall Ferguson (Toronto , Canada)
Noisy ventilation
Paolo Pelosi (Genoa , Italy)
Ventilator-induced diaphragm dysfunction: Clinical impact
Samir Jaber (Montpellier , France)
How to improve diaphragm function
Leo Heunks (Nijmegen , Netherlands)
Current status of proportional-assist ventilation
Dimitris Georgopoulos (Heraklion , Greece)
Impact of APRV on oxygen delivery
Brian Kavanagh (Toronto , Canada)
Benefits of proportional modes
Laurent Brochard (Toronto, Canada)
NAVA in patients with ARDS
Leo Heunks (Nijmegen , Netherlands)
PAV and NAVA are ideal modes of ventilation
Robert M Kacmarek (Boston , United States)
How to reconcile the use of paralytics and the need to preserve muscular activity in
ARDS
Laurent Papazian (Marseille , France)
Dealing with hypercapnia [Standard presentation]
When to treat
Andres Esteban (Madrid , Spain)
A place for therapeutic hypercapnia?
Brian Kavanagh (Toronto , Canada)
ECCO2R in mechanical ventilation
Michael Quintel (Göttingen , Germany)
ECCO2R to avoid endotracheal intubation for decompensated COPD
Marco Ranieri (Turin , Italy)
ARDS is not a disease [Standard presentation]
The Berlin definition is useful
Niall Ferguson (Toronto , Canada)
The Berlin definition is useless
Robert M Kacmarek (Boston , United States)
The Berlin definition is OK
Greg S Martin (Atlanta , United States)
Why have immunomodulation trials failed in ARDS?
Neil R MacIntyre (Durham , United States)
From the clinical to the molecular phenotype of ARDS
José Angel Lorente (Madrid , Spain)
Should we separate primary and secondary ARDS ?
Andres Esteban (Madrid , Spain)
Is ARDS different in children?
Brian Kavanagh (Toronto , Canada)
Biomarkers of ARDS: What, when and why?
José Angel Lorente (Madrid , Spain)
Quantitative diagnosis using extravascular lung water
Takashi Tagami (Tokyo, Japan)
Cell therapies [Standard presentation]
Stem cells as markers of sepsis and ARDS
Greg S Martin (Atlanta , United States)
Mesenchymal stromal cells in sepsis
Lauralyn McIntyre (Ottawa , Canada)
Mesenchymal stromal cells for ARDS
Taylor Thompson (Boston , United States)
Stem cells in ARDS
Paolo Pelosi (Genoa , Italy)
VILI revisited [Standard presentation]
Where does VILI start in the lungs?
Luciano Gattinoni (Milan , Italy)
PET: New questions and answers in dynamics of regional lung inflammation
Fernando Suarez Sipmann (Uppsala, Sweden)
Why young lungs are less sensitive
Brian Kavanagh (Toronto , Canada)
Lower tidal volumes for all?
Marcus Schultz (Amsterdam , Netherlands)
….including in patients with cardiogenic shock?
Karl Werdan (Halle , Germany)
Why did we ever use large tidal volumes?
Neil R MacIntyre (Durham , United States)
Protective ventilation in non-injured lungs: Tidal volume, PEEP or both?
Paolo Pelosi (Genoa , Italy)
How to enhance lung protection during spontaneously breathing
Tommaso Mauri (Monza , Italy)
Novel approaches to minimize VILI
Arthur S Slutsky (Toronto , Canada)
ARDS: Prevention rather than cure [Standard presentation]
ARDS can be largely prevented
Ognjen Gajic (Rochester , United States)
How can we prevent it?
Gavin Perkins (Warwick , United Kingdom)
The first week is crucial
Andres Esteban (Madrid , Spain)
The ARDS Network evolves to prevention
Taylor Thompson (Boston , United States)
Heart and lung [Standard presentation]
Heart-lung interactions from the lung perspective
Fernando Suarez Sipmann (Uppsala, Sweden)
Cardiovascular insufficiency during initiation and withdrawal of mechanical
ventilation
Michael Pinsky (Pittsburgh , United States)
Echocardiography to guide the management of pulmonary embolism
Anthony McLean (Sydney , Australia)
Inhaled therapies for right ventricular failure
Sven-Erik Ricksten (Gothenburg, Sweden)
Right ventricular protective ventilation
Antoine Vieillard-Baron (Boulogne-Billancourt , France)
Recruitment: When and how ? [Standard presentation]
Bedside measurement
Laurent Brochard (Toronto, Canada)
Evaluation by imaging
Davide Chiumello (Milan , Italy)
Evaluation by electrical impedance tomography (EIT)
Tommaso Mauri (Monza , Italy)
Different methods, different effects?
Paolo Pelosi (Genoa , Italy)
Effect on cardiac function
Michel Slama (Amiens , France)
Is it safe?-
Robert M Kacmarek (Boston , United States)
It should be performed in every patient with ARDS: Yes
Zsolt Molnar (Szeged , Hungary)
It should be performed in every patient with ARDS: No
Taylor Thompson (Boston , United States)
Prone positioning in ARDS [Standard presentation]
Prone positioning prevents VILI
John J Marini (St Paul , United States)
It also has beneficial hemodynamic effects
Antoine Vieillard-Baron (Boulogne-Billancourt , France)
In obese patients
Samir Jaber (Montpellier , France)
In intraabdominal hypertension
Manu Malbrain (Antwerp , Belgium)
High frequency ventilation: Is it passé ? [Standard presentation]
What went wrong in the clinical trials?
Niall Ferguson (Toronto , Canada)
Are OSCILLATE and OSCAR the final words?
Neil R MacIntyre (Durham , United States)
I still use it in ARDS
Jean-Daniel Chiche (Paris , France)
So, is there still a place for high-frequency ventilation?
Arthur S Slutsky (Toronto , Canada)
Respiratory monitoring [Standard presentation]
Lung imaging in ARDS
Davide Chiumello (Milan , Italy)
Electrical impedance tomography
Jean-Michel Constantin (Clermont-Ferrand , France)
Detection of pulmonary edema at the bedside
Daniel Reuter (Hamburg , Germany)
Chest X rays are obsolete, you only need echo
Paul H Mayo (New York , United States)
Should we measure transpulmonary pressure ? [Standard presentation]
Why measure it ?
Marco Ranieri (Turin , Italy)
How to measure it ?
Davide Chiumello (Milan , Italy)
What are the limitations ?
John J Marini (St Paul , United States)
Does it improve outcomes ?
Neil R MacIntyre (Durham , United States)
Monitoring in mechanical ventilation [Standard presentation]
Oxygen targets in mechanically ventilated patients
Rinaldo Bellomo (Melbourne, Australia)
How to monitor respiratory muscle function
Leo Heunks (Nijmegen , Netherlands)
How to monitor diaphragmatic function
Niall Ferguson (Toronto , Canada)
How to monitor lung mechanics
Robert M Kacmarek (Boston , United States)
The level of support based on EIT
Diederik Gommers (Rotterdam , Netherlands)
How monitoring can improve sleep
Laurent Brochard (Toronto, Canada)
PEEP titration [Standard presentation]
Which is the best PEEP trial?
Davide Chiumello (Milan , Italy)
PEEP protects the lung by decreasing tidal volume
Luciano Gattinoni (Milan , Italy)
Balancing competing goals in setting PEEP
Neil R MacIntyre (Durham , United States)
Using transpulmonary pressures to adjust PEEP in ARDS
Edgar Jimenez (Orlando , United States)
EIT is able to apply the "best" PEEP
Diederik Gommers (Rotterdam , Netherlands)
Don’t forget the hemodynamic effects
Antoine Vieillard-Baron (Boulogne-Billancourt , France)
Role of dead space, the forgotten physiological measurement
Fernando Suarez Sipmann (Uppsala, Sweden)
Extracorporeal gas exchange [Standard presentation]
ECMO retrieval team
Alain Combes (Paris , France)
ECMO: Latest fad or here to stay?
Niall Ferguson (Toronto , Canada)
ECCO2R in ARDS
Antonio Pesenti (Milan , Italy)
ECCO2R in severe asthma and COPD
Christian Karagiannidis (Köln, Germany)
Veno-venous ECMO: Nuts and boldts [Standard presentation]
Which kind of cannulation?
Alain Combes (Paris , France)
Patient-ventilator interactions
Antonio Pesenti (Milan , Italy)
How to improve oxygenation during ECMO
Bruno Levy (Vandoeuvre Les Nancy , France)
Full blown high-flow ECMO: When and how
Michael Quintel (Göttingen , Germany)
Awake ECMO: Indications and limitations
Tobias Welte (Hannover , Germany)
Infections related to ECMO: How to recognize and treat
Alain Combes (Paris , France)
Pharmacokinetics during ECMO
Fabio S Taccone (Brussels , Belgium)
Should it be used only in reference centers?
Laurent Papazian (Marseille , France)
My idea is not so crazy [Standard presentation]
Nitroprusside, lipids and estrogens in CPR
Paul E Pepe (Dallas , United States)
Inhaled NO to protect the brain
Fumito Ichinose (Charlestown , United States)
Suspended animation with hydrogen sulfide
Mervyn Singer (London , United Kingdom)
We should give EPO to all critically ill patients
Peter Radermacher (Ulm , Germany)
Breathomics to diagnose (almost) everything
Marcus Schultz (Amsterdam , Netherlands)
Take care when translating ´´clever´´ ideas
Brian Kavanagh (Toronto , Canada)
Challenges in intubation [Standard presentation]
Only supraglottic airways in CPR?
Jerry Nolan (Bath , United Kingdom)
No place left for nasotracheal intubation?
Eric Maury (Paris , France)
Video laryngoscopy should be the preferred technique
Paul H Mayo (New York , United States)
We could do it better
Samir Jaber (Montpellier , France)
Tracheostomy early, late or never [Standard presentation]
Minimizing risk during dilatational percutaneous tracheostomy
Axel Nierhaus (Hamburg , Germany)
How to do it better
Paolo Pelosi (Genoa , Italy)
Longer term outcomes
Alain Combes (Paris , France)
Patients like tracheostomy
Marek Mirski (Baltimore , United States)
Weaning [Standard presentation]
Weaning - art or science?
Georg-Christian Funk (Vienna , Austria)
Failure of cardiac origin
Xavier Monnet (Le Kremlin-Bicêtre , France)
Failure from muscle weakness
Andres Esteban (Madrid , Spain)
NIV as a tool
Gavin Perkins (Warwick , United Kingdom)
Weaning and extubation in obese patients
Samir Jaber (Montpellier , France)
Do we need dedicated weaning centers?
Jeremy M Kahn (Pittsburgh , United States)
Non-invasive ventilation [Standard presentation]
In the post-operative patient
Samir Jaber (Montpellier , France)
Should we always try it in COPD?
Georg-Christian Funk (Vienna , Austria)
For pneumonia
Massimo Antonelli (Rome , Italy)
For severe CAP
Antoni Torres (Barcelona , Spain)
In immunocompromised patients
Dominique Benoit (Ghent , Belgium)
How inflammatory markers can help
Giuseppe Biondi-Zoccai (Rome, Italy)
CPAP and NIV: Practical considerations [Standard presentation]
NIV outside the ICU
Paolo Navalesi (Novara , Italy)
Non-invasive CPAP outside the ICU
Paolo Pelosi (Genoa , Italy)
Role of the upper airways in the success of NIV
Leo Heunks (Nijmegen , Netherlands)
Leak compensation: Invasive versus non-invasive ventilators
Robert M Kacmarek (Boston , United States)
Applying NIV by NAVA: Why, when and how
Paolo Navalesi (Novara , Italy)
What to do when NIV fails in a COPD
Christian Karagiannidis (Köln, Germany)
When is the right time to intubate?
Andres Esteban (Madrid , Spain)
Unless we have a do-not-intubate order?
Elie Azoulay (Paris , France)
How much oxygen ? [Standard presentation]
Human tolerance of extreme hypoxemia
Monty G Mythen (London , United Kingdom)
Patient intolerance to hypoxemia
Michael Quintel (Göttingen , Germany)
Effects of hypoxia on the immune response
Peter Pickkers (Nijmegen , Netherlands)
Hyperoxia can be beneficial
Peter Radermacher (Ulm , Germany)
A place for hyperoxia in shock states
Fuhong Su (Brussels , Belgium)
Standardized approach to severe hypoxemia
Ognjen Gajic (Rochester , United States)
A place for permissive hypoxemia?
Mervyn Singer (London , United Kingdom)
Sedation & analgesia [Standard presentation]
Moderators : Jean-Michel Constantin (Clermont-Ferrand , France)
Trials of sedation have advanced our practice
E Wesley Ely (Nashville , United States)
Trials of sedation have contributed little
Jukka Takala (Bern , Switzerland)
Sedation strategies in the neuro-ICU
Geert Meyfroidt (Leuven , Belgium)
Ketamine is the best
Paul Wischmeyer (Aurora , United States)
Clonidine is ideal
Patrice Forget (Brussels , Belgium)
I'd like to sleep
Dimitris Georgopoulos (Heraklion , Greece)
A place for volatile anesthetics?
Antonio Pesenti (Milan , Italy)
Improved analgesia management may improve outcome
Samir Jaber (Montpellier , France)
Delirium [Standard presentation]
Prevention
Stephan A Mayer (New York , United States)
Prediction
Peter Pickkers (Nijmegen , Netherlands)
Long-term outcomes
E Wesley Ely (Nashville , United States)
Early mobilization [Standard presentation]
Moderators : Michael Ramsay (Dallas , United States)
Getting ICU patients back to baseline
Theodore J Iwashyna (Ann Arbor, United States)
Muscle metabolism
Greet Van Den Berghe (Leuven , Belgium)
Physiotherapy for ICU-acquired weakness
Evelyn Corner (London, United Kingdom)
Do we need a trial on this?
Paul Young (Wellington, New Zealand)
We should mobilize both body and brain
E Wesley Ely (Nashville , United States)
Hemodynamic monitoring [Standard presentation]
Bedside assessment of total cardiovascular status
Michael Pinsky (Pittsburgh , United States)
We can trust uncalibrated cardiac output monitors for the ICU : Yes
Charles S Brudney (Durham , United States)
We can trust uncalibrated cardiac output monitors for the ICU : No
Xavier Monnet (Le Kremlin-Bicêtre , France)
Widening patient access to flow monitoring from ICU to OR to general ward
Max Jonas (Southampton , United Kingdom)
Functional electrical impedance tomography
Daniel Reuter (Hamburg , Germany)
Determination of cardiac output by transthoracic echocardiography (TTE)
Paolo Navalesi (Novara , Italy)
Other non-invasive hemodynamic monitoring
Andreas Hoeft (Bonn , Germany)
Is there a place for these systems in the ICU?
Matthieu Biais (Bordeaux, France)
Accuracy and precision of the various cardiac output monitoring systems
Maurizio Cecconi (London , United Kingdom)
Hemodynamic monitoring: What’s the evidence . and does it matter?
Azriel Perel (Tel Aviv , Israel)
Hemodynamic monitoring - numbers to treat?
Jukka Takala (Bern , Switzerland)
Resuscitation towards the microcirculation [Standard presentation]
Traditional resuscitation strategies and endpoints
Lauralyn McIntyre (Ottawa , Canada)
The microcirculation in obstructive and septic shock
Jan Bakker (Rotterdam , Netherlands)
Subcellular compartments: The glycocalyx and the mitochondria
Can Ince (Amsterdam , Netherlands)
CO2 tonometry in the ICU
Didier Payen (Paris , France)
We need to monitor tissue oxygenation
Mervyn Singer (London , United Kingdom)
Colloids vs crystalloids [Standard presentation]
The physiologic basis
Can Ince (Amsterdam , Netherlands)
Is physiology wrong?
Zsolt Molnar (Szeged , Hungary)
How the type of fluid can influence immune status
Didier Payen (Paris , France)
HES storage: A comprehensive review
Christian J Wiedermann (Bolzano , Italy)
Does HES storage have pathophysiological relevance?
Michael Joannidis (Innsbruck , Austria)
Does HES really alter renal function?
Claude Martin (Marseille , France)
Why HES may increase mortality in sepsis
Anders Perner (Copenhagen , Denmark)
Could we develop new colloids?
Jyrki Tenhunen (Uppsala, Sweden)
Colloids are not dead!
Djillali Annane (Garches , France)
Type of fluids in various conditions [Standard presentation]
In acute brain injury
Peter Andrews (Edinburgh , United Kingdom)
In trauma
Andrew Shaw (Durham , United States)
In ARDS
Greg S Martin (Atlanta , United States)
In the OR
Gernot Marx (Aachen , Germany)
In diabetic ketoacidosis
Balasubramanian Venkatesh (Brisbane , Australia)
In hepatorenal syndrome
Pere Ginès (Barcelona, Spain)
The end of saline solutions ? [Standard presentation]
Saline is bad
John Kellum (Pittsburgh , United States)
The case for 0.9%NaCl
Can Ince (Amsterdam , Netherlands)
It is still OK to give normal saline: Yes
Simon Finfer (Sydney , Australia)
It is still OK to give normal saline: No
Monty G Mythen (London , United Kingdom)
We need a SPLIT trial
Paul Young (Wellington, New Zealand)
What should we study next?
Paul Young (Wellington, New Zealand)
Albumin [Standard presentation]
Review of pharmacology
Albert Farrugia (Perth, Australia)
Metabolism in the severely ill
Jan Wernerman (Stockholm , Sweden)
Biological effects in cirrhosis
Paolo Angeli (Padova , Italy)
Albumin for resuscitation
Lauralyn McIntyre (Ottawa , Canada)
Albumin supplementation
Massimo Antonelli (Rome , Italy)
The Albios study: Resuscitation and/or supplementation
Luciano Gattinoni (Milan , Italy)
How much fluid? [Standard presentation]
When do we need a fluid challenge?
Jean-Louis Vincent (Brussels , Belgium)
How do we guide it? The Fenice study
Daniel De Backer (Brussels , Belgium)
The hemodynamic effects of a fluid bolus
Rinaldo Bellomo (Melbourne, Australia)
How to monitor the effects of fluid administration
Xavier Monnet (Le Kremlin-Bicêtre , France)
The use of mean systemic filling pressure in fluid resuscitation
Jan Bakker (Rotterdam , Netherlands)
How to assess preload in intraabdominal hypertension
Jan De Waele (Ghent , Belgium)
Fluid balance in severe sepsis: The lower the better?
Yasser Sakr (Jena , Germany)
Could rapid determination of plasma volume help?
Bruce A Molitoris (Indianapolis , United States)
Fluid resuscitation should be guided by . [Standard presentation]
Fluid responsiveness
Jean-Louis Teboul (Le Kremlin-Bicêtre , France)
Cardiac output and/or stroke volume
Michael Sander (Berlin , Germany)
Urine analysis
Luciano Gattinoni (Milan , Italy)
ScvO2
Stephen Trzeciak (Camden , United States)
Extravascular lung water
Mikhail Kirov (Arkhangelsk , Russia)
The peripheral circulation
Jan Bakker (Rotterdam , Netherlands)
The microcirculation
Daniel De Backer (Brussels , Belgium)
The pros and cons of fluid responsiveness [Standard presentation]
Pulse pressure vs stroke volume variation
Maurizio Cecconi (London , United Kingdom)
Assessment in spontaneously breathing patients
Xavier Monnet (Le Kremlin-Bicêtre , France)
Can we use non-invasive tools?
Patrice Forget (Brussels , Belgium)
How it's affected by patient-ventilator synchrony
Paolo Navalesi (Novara , Italy)
Limitations of using pulse pressure variation
Michel Slama (Amiens , France)
Fluid unresponsiveness should be avoided
Jan Bakker (Rotterdam , Netherlands)
In the emergency room [Standard presentation]
Overcrowding
Martin Möckel (Berlin, Germany)
Risk stratification with biomarkers
Christian H Nickel (Basel , Switzerland)
Critical care ultrasonography of the whole body
Paul H Mayo (New York , United States)
The battered child
Philippe Jorens (Edegem , Belgium)
Drugs of abuse: A shifting landscape
Janice L. Zimmerman (Houston , United States)
Intoxications: Indications for extracorporeal support
Patrick Honoré (Brussels , Belgium)
Risk stratification in burn injury
Stijn Blot (Ghent , Belgium)
Anaphylaxis
Jerrold H Levy (Durham, United States)
Neurologic emergencies [Standard presentation]
Mannitol vs hypertonic saline for cerebral edema
Marek Mirski (Baltimore , United States)
Call the neurosurgeon now
Peter Le Roux (Wynnewood, United States)
Endovascular therapy for stroke
Stephan A Mayer (New York , United States)
Status epilepticus
Mauro Oddo (Lausanne , Switzerland)
Severe heart failure [Standard presentation]
Optimal vasopressor use
Bruno Levy (Vandoeuvre Les Nancy , France)
Still a place for balloon pump?
Karl Werdan (Halle , Germany)
Routine use of ultrafiltration?
Amir Kazory (Gainesville, United States)
High volume hemofiltration is HEROIC
Alain Combes (Paris , France)
Diastolic dysfunction: What to do about it?
Jan Poelaert (Brussels , Belgium)
Cardiovascular alterations in sepsis [Standard presentation]
Basics of vascular hyporesponsiveness in septic shock
Bruno Levy (Vandoeuvre Les Nancy , France)
Basics of septic cardiomyopathy
Andreas Hoeft (Bonn , Germany)
Systolic and/or diastolic function
Michel Slama (Amiens , France)
Does it really matter?
Antoine Vieillard-Baron (Boulogne-Billancourt , France)
Does it really predict outcome?
Anthony McLean (Sydney , Australia)
High risk surgery [Standard presentation]
How big is the problem?
Berthold Bein (Kiel , Germany)
Enhanced recovery after surgery
Monty G Mythen (London , United Kingdom)
Intraoperative risk assessment
Stefan De Hert (Ghent , Belgium)
Prevention of perioperative aspiration
Jan Poelaert (Brussels , Belgium)
Ventilator management during surgery
Paolo Pelosi (Genoa , Italy)
Ventilatory management of the obese perioperative patient
Samir Jaber (Montpellier , France)
Postoperative respiratory depression can be harmful
Michael Ramsay (Dallas , United States)
Improving outcomes for emergency laparotomy
Nial Quiney (Guildford , United Kingdom)
Preventing renal failure after cardiac surgery
Alain Combes (Paris , France)
Detecting complications outside the ICU
Andreas Hoeft (Bonn , Germany)
Long-term effects of postoperative complications
Maurizio Cecconi (London , United Kingdom)
Goal-directed perioperative optimization [Standard presentation]
Current status
Andrew Rhodes (London , United Kingdom)
Options for cardiac output monitoring
Simon Davies (York, United Kingdom)
Fluid management
Monty G Mythen (London , United Kingdom)
The unanswered questions
Azriel Perel (Tel Aviv , Israel)
Traumatic brain injury [Standard presentation]
Oxygen therapy and ventilator management
Peter Andrews (Edinburgh , United Kingdom)
Fever control
Paul Young (Wellington, New Zealand)
Imaging
Paul Vespa (Los Angeles , United States)
Neuromonitoring
Peter Le Roux (Wynnewood, United States)
Raised ICP - a thing of the past?
Peter Andrews (Edinburgh , United Kingdom)
Intracranial hypertension can be largely prevented
Geert Meyfroidt (Leuven , Belgium)
When is aggressive therapy required?
Nino Stocchetti (Milan , Italy)
Time is critical
Marek Mirski (Baltimore , United States)
Therapeutic hypothermia [Standard presentation]
Host response
Nicole Juffermans (Amsterdam , Netherlands)
Metabolic effects
Arthur Van Zanten (Ede , Netherlands)
Temperature management in trauma: Warm, cool, or inbetween?
Michael Reade (Herston QLD, Australia)
Brain cooling: Challenges and potential rewards
Peter Andrews (Edinburgh , United Kingdom)
Pitfalls of rewarming
Janice L. Zimmerman (Houston , United States)
Neuromonitoring [Standard presentation]
Inside the black box: Brain multimodality monitoring
Stephan A Mayer (New York , United States)
Brain oxygen and metabolism in neurocritical care
Peter Le Roux (Wynnewood, United States)
Hemodynamic monitoring
Fabio S Taccone (Brussels , Belgium)
Spreading depolarizations
Raimund Helbok (Innsbruck , Austria)
Can we reach a consensus?
Giuseppe Citerio (Monza , Italy)
Neurological challenges [Standard presentation]
Autoimmune encephalitis
Raimund Helbok (Innsbruck , Austria)
Refractory status epilepticus
Stephan A Mayer (New York , United States)
Neurogenic pulmonary edema
Lakhmir Chawla (Washington , United States)
Septic encephalopathy
Fabio S Taccone (Brussels , Belgium)
Intracerebral hemorrhage [Standard presentation]
Stop the bleeding
Stephan A Mayer (New York , United States)
Optimal blood pressure
Paul Vespa (Los Angeles , United States)
Conservative treatment
Nino Stocchetti (Milan , Italy)
When to operate
Peter Le Roux (Wynnewood, United States)
Subarachnoid hemorrhage: New Strategies [Standard presentation]
Early brain injury
Raimund Helbok (Innsbruck , Austria)
Delayed ischemia
Nino Stocchetti (Milan , Italy)
Vasospasm management
Peter Le Roux (Wynnewood, United States)
Coagulopathies [Standard presentation]
Update on HIT
Jerrold H Levy (Durham, United States)
Utility of TEG/ROTEM to detect hypercoagulability in ICU patients
Nicole Juffermans (Amsterdam , Netherlands)
von Willebrand factor in critical care
Beverley Hunt (London , United Kingdom)
In sepsis
Tom van der Poll (Amsterdam , Netherlands)
In liver disease
Julia Wendon (London , United Kingdom)
A place for fresh frozen plasma in the non-bleeding patient
Janice L. Zimmerman (Houston , United States)
Is it necessary to correct coagulopathy prior to an invasive procedure?
Nicole Juffermans (Amsterdam , Netherlands)
Dealing with old and new antithrombotics [Standard presentation]
Reversing the effects of vitamin K antagonists
Truman Milling (Austin, United States)
New oral anticoagulants: The evolving story
Beverley Hunt (London , United Kingdom)
Use of new oral anticoagulants
Jerrold H Levy (Durham, United States)
Oral anticoagulant-induced bleeding
Christian J Wiedermann (Bolzano , Italy)
Antagonizing the effects of oral antiplatelet agents
Giuseppe Biondi-Zoccai (Rome, Italy)
Massive bleeding [Standard presentation]
Pathophysiology of hemorrhagic shock
Matthieu Biais (Bordeaux, France)
Obstetric hemorrhage
Beverley Hunt (London , United Kingdom)
Bleeding complications in sepsis
Anders Perner (Copenhagen , Denmark)
How much FFP?
Kai Zacharowski (Frankfurt , Germany)
How many platelet transfusions?
Michael Hiesmayr (Vienna , Austria)
Fibrinogen to boost coagulation?
Jacques Duranteau (Le Kremlin-Bicêtre , France)
Tranexamic acid: More than an antifibrinolytic drug?
Beverley Hunt (London , United Kingdom)
Desmopressin?
Giovanni Landoni (Milan, Italy)
A summary of our new concepts
Jerrold H Levy (Durham, United States)
A place for fresh blood against blood bank policies?
Albert Farrugia (Perth, Australia)
Transfusion [Standard presentation]
Non-bleeding causes of anemia
Peter Pickkers (Nijmegen , Netherlands)
Patient blood management: A clinical trial
Kai Zacharowski (Frankfurt , Germany)
Review of transfusion triggers in the critically ill
Lauralyn McIntyre (Ottawa , Canada)
The beneficial effects of blood transfusions
Can Ince (Amsterdam , Netherlands)
7 g/dL threshold for all?
Yasser Sakr (Jena , Germany)
10 g/dL threshold for some
Marek Mirski (Baltimore , United States)
Triggers in neurocritical care
Peter Le Roux (Wynnewood, United States)
Triggers in coronary artery disease
Philippe Van Der Linden (Brussels , Belgium)
Triggers in septic shock
Anders Perner (Copenhagen , Denmark)
ScvO2 and CO2-gap as triggers
Zsolt Molnar (Szeged , Hungary)
Does age of blood matter?
Lauralyn McIntyre (Ottawa , Canada)
Polytrauma [Standard presentation]
Hemodynamic monitoring
Jacques Duranteau (Le Kremlin-Bicêtre , France)
Abdominal trauma
John C Marshall (Toronto , Canada)
Pelvic fracture
Jacques Duranteau (Le Kremlin-Bicêtre , France)
Liver trauma
Julia Wendon (London , United Kingdom)
Quality indicators
Michael Reade (Herston QLD, Australia)
VAP [Standard presentation]
Are ventilator-associated events different from VAP? Yes
Robert M Kacmarek (Boston , United States)
Are ventilator-associated events different from VAP? No
Clifford S Deutschman (Philadelphia , United States)
Update on VAP management
Michael S Niederman (Mineola , United States)
VAP as a source of antimicrobial overuse
Jean Chastre (Paris , France)
Inhaled antibiotics for VAP: The next major breakthrough?
Marin Kollef (St Louis , United States)
Maybe not
Tobias Welte (Hannover , Germany)
Is it time to develop new guidelines?
Antoni Torres (Barcelona , Spain)
VAP: Preventive measures [Standard presentation]
Mod
Tommaso Mauri (Monza , Italy)
How much is preventable?
Marin Kollef (St Louis , United States)
Prevention by oral care
Stijn Blot (Ghent , Belgium)
Mucus flow and physiotherapy
Antoni Torres (Barcelona , Spain)
Liver failure [Standard presentation]
Acute liver failure: Syndromes and management
Julia Wendon (London , United Kingdom)
Acute-on-chronic
Pere Ginès (Barcelona, Spain)
Perioperative management
Michael Ramsay (Dallas , United States)
Feeding the cirrhotic patient
Pierre-François Laterre (Brussels , Belgium)
Renal failure in cirrhosis
Paolo Angeli (Padova , Italy)
Liver dialysis: Quo vadis?
Alexander Wilmer (Leuven , Belgium)
Pancreatitis [Standard presentation]
Basic principles in managing a complex disease
John C Marshall (Toronto , Canada)
Cardiovascular management
Daniel Reuter (Hamburg , Germany)
Respiratory management
Samir Jaber (Montpellier , France)
Early enteral feeding for all?
Stephen McClave (Louisville, United States)
When to give antibiotics and antifungals
Philippe Montravers (Paris , France)
Nutritional support [Standard presentation]
Nutrition and autophagy during critical illness
Greet Van Den Berghe (Leuven , Belgium)
How stress influences the gut
Pierre Déchelotte (Rouen , France)
Malnutrition and outcomes
Kenneth Christopher (Boston, United States)
Refeeding syndrome in the ICU
Michael Hiesmayr (Vienna , Austria)
Obesity and outcome
Yasser Sakr (Jena , Germany)
Malabsorption of nutrients in the critically ill
Adam Deane (Adelaide , Australia)
Fasting as a risk factor for adverse renal outcomes?
Ravindra Mehta (San Diego , United States)
Enteral and/or parenteral routes: Resolving controversies
Paul Wischmeyer (Aurora , United States)
Not all ICU patients will benefit
Daren K Heyland (Kingston , Canada)
When is permissive underfeeding appropriate?
Stephen McClave (Louisville, United States)
Special nutrients [Standard presentation]
Glutamine and antioxidants: An update
Daren K Heyland (Kingston , Canada)
Glutamine supplementation should now be avoided
Arthur Van Zanten (Ede , Netherlands)
The role of omega-3 fatty acid, gamma-linolenic acid, and antioxidant
supplementation
Taylor Thompson (Boston , United States)
Still a place for anti-oxidants?
Paul Van Leeuwen (Amsterdam , Netherlands)
Adding vitamin D for everyone?
Kenneth Christopher (Boston, United States)
How to assess the risks of special nutrients
Jean-Charles Preiser (Brussels , Belgium)
Protein is the most important nutrient in the ICU
Paul Wischmeyer (Aurora , United States)
Nutritional support in special circumstances [Standard presentation]
In the critically ill obese
Paul Wischmeyer (Aurora , United States)
In acute renal failure
Enrico Fiaccadori (Parma , Italy)
In pancreatitis
Pierre-François Laterre (Brussels , Belgium)
In cirrhosis
Julia Wendon (London , United Kingdom)
Glucose control in 2014 [Standard presentation]
Glucose: A pro-inflammatory substrate
Didier Payen (Paris , France)
Has anything happened since NICE-SUGAR?
James Krinsley (Stamford , United States)
Intensive insulin therapy trialists’ collaboration: A meta-analysis of individual data
Simon Finfer (Sydney , Australia)
Similar targets after acute brain injury?
Mauro Oddo (Lausanne , Switzerland)
What about diabetics?
James Krinsley (Stamford , United States)
Near-continuous glucose monitoring
Jean-Charles Preiser (Brussels , Belgium)
Pharmaconutrition and insulin resistance
Pierre Déchelotte (Rouen , France)
Novel therapies to treat hyperglycemia without causing hypoglycemia
Adam Deane (Adelaide , Australia)
Enteral nutrition [Standard presentation]
Swallowing disorders: A treatable risk factor
Michael Hiesmayr (Vienna , Austria)
Early enteral nutrition: Does the route matter?
Stephen McClave (Louisville, United States)
Feeding in the jejunum is better than in the stomach
Paul Van Leeuwen (Amsterdam , Netherlands)
Intragastric versus small intestinal delivery
Adam Deane (Adelaide , Australia)
Importance of high-protein enteral nutrition
Arthur Van Zanten (Ede , Netherlands)
Energy requirements: How early and how much? [Standard presentation]
Calculating energy needs in critically ill patients: Sense or nonsense?
Herbert Spapen (Brussels , Belgium)
Should we use indirect calorimetry in the ICU
Stephen McClave (Louisville, United States)
How to define caloric needs
Jean-Charles Preiser (Brussels , Belgium)
Antimicrobial strategies [Standard presentation]
Death by antibiotic
Richard Wunderink (Chicago , United States)
A review of recent anti-Gram-positive drugs
Robert Masterton (Ayrshire, United Kingdom)
A recent review of anti-Gram negative drugs
Mark Wilcox (Leeds , United Kingdom)
Optimizing therapy with beta-lactam antibiotics
Jan De Waele (Ghent , Belgium)
Have we outsmarted ourselves with PK/PD optimization
Richard Wunderink (Chicago , United States)
Brain toxicity of beta-lactams
Fabio S Taccone (Brussels , Belgium)
Combination antibiotic therapy
Thierry Calandra (Lausanne , Switzerland)
Mono versus bi-therapy in Pseudomonas infections
Jean Chastre (Paris , France)
De-escalation of antibiotic treatment for all
Claude Martin (Marseille , France)
De-escalation is not always possible
Jan De Waele (Ghent , Belgium)
Duration of antibiotic therapy
Jean-François Timsit (Paris, France)
Infectious threats - Pandemics [Standard presentation]
Emerging infectious diseases in a shrinking world
Thierry Calandra (Lausanne , Switzerland)
Developing quick diagnostic tests
Richard Rothman (Baltimore, United States)
How the critical care community should react
John C Marshall (Toronto , Canada)
Personal protective strategies
Edgar Jimenez (Orlando , United States)
Disasters [Standard presentation]
Ready for the next disaster?
Paul E Pepe (Dallas , United States)
Wounds to expect after an explosion
Michael Reade (Herston QLD, Australia)
Emergency mass critical care
Niranjan (Tex) Kissoon (Vancouver , Canada)
ICU preparedness in mass casualty incidents
Edgar Jimenez (Orlando , United States)
Nosocomial infections [Standard presentation]
Rapid molecumar testing
Richard Rothman (Baltimore, United States)
The microbial flora of critical illness: What does it tell us?
John C Marshall (Toronto , Canada)
Chlorhexidine: Anyone for a bath?
Mark Wilcox (Leeds , United Kingdom)
A place for probiotics in critical care?
Paul Wischmeyer (Aurora , United States)
Hospital-acquired pneumonia
Richard Wunderink (Chicago , United States)
Prevention of catheter-related infections
Jean-François Timsit (Paris, France)
Adenovirus infections
François Simon (Paris, France)
An algorithm to treat healthcare-associated pneumonia in the ICU
Michael S Niederman (Mineola , United States)
Multiresistant organisms [Standard presentation]
Risk factors for MDR pathogens in the ICU
Michael S Niederman (Mineola , United States)
C. difficile infection: Where next?
Mark Wilcox (Leeds , United Kingdom)
Recent infection control developments in the ICU
Robert Masterton (Ayrshire, United Kingdom)
Multidrug resistance strains in intraabdominal infections
Philippe Montravers (Paris , France)
New technologies for infection diagnostics
François Simon (Paris, France)
Early recognition of resistant bacteria
Robert Bonomo (Cleveland, United States)
Intelligent use of antibiotics to limit antibiotic resistance
Steven Opal (Providence , United States)
Antibiotic treatment in the era of MDR pathogens
Tobias Welte (Hannover , Germany)
How to treat carbapenemase-producing enterobacteriaceae?
Matteo Bassetti (Udine, Italy)
How to use colistin?
Arthur Van Zanten (Ede , Netherlands)
Aerosolized antibiotics for resistant organisms
Massimo Antonelli (Rome , Italy)
What new antibiotics are in the pipeline?
Matteo Bassetti (Udine, Italy)
Viral and fungal infections [Standard presentation]
Herpes simplex in the ICU
Philippe Jorens (Edegem , Belgium)
Should we treat cytomegalovirus reactivation?
Laurent Papazian (Marseille , France)
Sepsis in HIV patients
Tom van der Poll (Amsterdam , Netherlands)
Candida sepsis
Thierry Calandra (Lausanne , Switzerland)
Intra-abdominal candidiasis: Management recommendations
Matteo Bassetti (Udine, Italy)
Candida infection: Epidemiology and markers
Antonio Messias (Loures, Portugal)
Role of biomarker-based pre-emptive antifungal therapy
Markus Ruhnke (Berlin , Germany)
The importance of empiric therapy for Candida in nosocomial septic shock
Marin Kollef (St Louis , United States)
Candida in the lung: Should we treat it?
Daren K Heyland (Kingston , Canada)
Aspergillus infections in the ICU
Elie Azoulay (Paris , France)
Bicarbonate administration: A reappraisal [Standard presentation]
In severe lactic acidosis
Bruno Levy (Vandoeuvre Les Nancy , France)
In non-lactic metabolic acidosis
Patrick Honoré (Brussels , Belgium)
In respiratory acidosis
Antonio Pesenti (Milan , Italy)
To protect the kidney
Rinaldo Bellomo (Melbourne, Australia)
Electrolyte and acid-base [Standard presentation]
A new look at dysnatremia
Michael Darmon (Saint-Priest-en-Jarez, France)
Biomarkers for the differential diagnosis of hyponatremia
Mirjam Christ-Crain (Basel, Switzerland)
Management of hyponatremia - Guidelines
Djillali Annane (Garches , France)
Magnesium: The forgotten ion
Figen Esen (Istanbul , Turkey)
Chloride: The key electrolyte in acid-base control
Luciano Gattinoni (Milan , Italy)
Metabolic alkalosis
Enrico Fiaccadori (Parma , Italy)
Monitoring the kidney [Standard presentation]
The continuing spectrum from mild pre-renal to end-stage renal failure
Claudio Ronco (Vicenza , Italy)
Cell cycle arrest biomarkers
John Kellum (Pittsburgh , United States)
Novel biomarkers
Rinaldo Bellomo (Melbourne, Australia)
Renal biomarkers: How to use them in practice
Andrew Shaw (Durham , United States)
Measured GFR: Is it useful?
Bruce A Molitoris (Indianapolis , United States)
Assessment of renal perfusion using renal Doppler
Michael Darmon (Saint-Priest-en-Jarez, France)
Contrast-enhanced ultrasound
Jacques Duranteau (Le Kremlin-Bicêtre , France)
The renal stress test
Lakhmir Chawla (Washington , United States)
The injured kidney [Standard presentation]
The renal microcirculation in sepsis
Can Ince (Amsterdam , Netherlands)
A role for adenosine receptor agonists and antagonists?
Patrick Honoré (Brussels , Belgium)
How the kidneys recover
Miet Schetz (Leuven , Belgium)
Preventing renal failure [Standard presentation]
Protection of renal function in the ICU
Michael Joannidis (Innsbruck , Austria)
How to improve renal perfusion, filtration and oxygenation
Sven-Erik Ricksten (Gothenburg, Sweden)
Biomarkers to define the pathophysiology
Michael Joannidis (Innsbruck , Austria)
Validation of a risk score
Ravindra Mehta (San Diego , United States)
In high-risk surgical patients
Yahya Shehabi (Randwick, Australia)
Fenoldopam in renal protection
Giovanni Landoni (Milan, Italy)
Contrast induced nephropathy: Does anything work?
Claudio Ronco (Vicenza , Italy)
My checklist
Eric Hoste (Ghent , Belgium)
Renal replacement therapy [Standard presentation]
Would outcomes be worse without renal replacement therapy?
Sean Bagshaw (Edmonton , Canada)
Optimal timing
John Kellum (Pittsburgh , United States)
Should we start earlier in the presence of lactate-associated acidosis?
Eric Hoste (Ghent , Belgium)
Does the type of RRT influence renal recovery?-
Rinaldo Bellomo (Melbourne, Australia)
How to prescribe the appropriate dose and type of fluids
Claudio Ronco (Vicenza , Italy)
Permissive hypofiltration
Lakhmir Chawla (Washington , United States)
Optimizing hemodynamic stability during RRT
Ravindra Mehta (San Diego , United States)
SLED in the ICU
Enrico Fiaccadori (Parma , Italy)
My protocol for citrate anticoagulation
Miet Schetz (Leuven , Belgium)
Citrate anticoagulation: Not for every case
Patrick Honoré (Brussels , Belgium)
Regional citrate vs heparin anticoagulation: A new study
David Gattas (Sydney , Australia)
Extracorporeal therapies in sepsis [Standard presentation]
They are useless
Miet Schetz (Leuven , Belgium)
The Abdomix study
Didier Payen (Paris , France)
Combined plasma filtration and adsorption (CPFA) may be valuable
Giorgio Berlot (Trieste , Italy)
High volume hemofiltration: Good or bad?
Michael Joannidis (Innsbruck , Austria)
CPR [Standard presentation]
No ventilation CPR
Paul E Pepe (Dallas , United States)
Is it worthwhile attempting CPR in traumatic cardiac arrest?
Michael Reade (Herston QLD, Australia)
Update on mechanical chest compression devices
Kjetil Sunde (Oslo , Norway)
Impedance threshold devices for CPR: Fact or fiction?
Giuseppe Biondi-Zoccai (Rome, Italy)
Ventilation during CPR
Laurent Brochard (Toronto, Canada)
What we know about defibrillation today
Lars Wik (Oslo, Norway)
Should we still use epinephrine?
Jerry Nolan (Bath , United Kingdom)
Percutaneous circulatory support in CPR
Michael Fries (Aachen , Germany)
Should we rescue out-of-hospital cardiac arrest with ECMO?
Alain Combes (Paris , France)
Improving quality through feedback and debriefing
Gavin Perkins (Warwick , United Kingdom)
The fifth link in the “Chain of Survival” concept
Takashi Tagami (Tokyo, Japan)
Is there a role for ‘cardiac arrest centers’?
Jerry Nolan (Bath , United Kingdom)
The future of CPR [Standard presentation]
Stutter CPR
Paul E Pepe (Dallas , United States)
Hydrogen sulfide as a life-saver
Fumito Ichinose (Charlestown , United States)
Post-cardiac arrest care: Future roads
Niklas Nielsen (Helsingborg, Sweden)
After cardiac arrest [Standard presentation]
Immediate coronary angiography after all cardiac arrests?: Yes
Giuseppe Biondi-Zoccai (Rome, Italy)
Immediate coronary angiography after all cardiac arrests?: No
Kjetil Sunde (Oslo , Norway)
Respiratory care: What are the targets?
Niklas Nielsen (Helsingborg, Sweden)
Oxygen and carbon dioxide management following cardiac arrest
Paul Young (Wellington, New Zealand)
New therapeutic measures to improve organ function
Stephen Trzeciak (Camden , United States)
Postanoxic brain damage [Standard presentation]
Prognostication
Massimo Antonelli (Rome , Italy)
New biomarkers
Michael Joannidis (Innsbruck , Austria)
New data on biomarkers
Hans Friberg (Lund , Sweden)
Place of EEG
Hans Friberg (Lund , Sweden)
Multimodal prognostication
Mauro Oddo (Lausanne , Switzerland)
Measuring consciousness with a number
Steven Laureys (Liège , Belgium)
Protecting the brain after cardiac arrest [Standard presentation]
Will fast and early cooling further improve survival?
Kjetil Sunde (Oslo , Norway)
Target temperature: 33 vs 36°C
Niklas Nielsen (Helsingborg, Sweden)
Should non-VF arrest patients be cooled?
Kjetil Sunde (Oslo , Norway)
Optimal blood pressure
Fabio S Taccone (Brussels , Belgium)
Optimal heart rate
Kjetil Sunde (Oslo , Norway)
Optimal ventilator strategy
Jyrki Tenhunen (Uppsala, Sweden)
Xenon in combination with hypothermia
Michael Fries (Aachen , Germany)
Novel neuroprotective strategies
Fumito Ichinose (Charlestown , United States)
What is the overall outcome?
Hans Friberg (Lund , Sweden)
Rapid response systems [Standard presentation]
Automated triggering?
Jyrki Tenhunen (Uppsala, Sweden)
Routine lab test to identify at risk patients
Rinaldo Bellomo (Melbourne, Australia)
The nurses are the best trigger
Arthur Van Zanten (Ede , Netherlands)
An electronic early warning system to improve outcomes in hospitalized patients
Marin Kollef (St Louis , United States)
A new Australian study
David Gattas (Sydney , Australia)
Rescue of medically deteriorating patients
Naeem Ali (Columbus , United States)
Proactive systems: How to implement the next generation?
Edgar Jimenez (Orlando , United States)
Implementing a rapid response system in your hospital
Ken Hillman (Liverpool , Australia)
After the ICU [Standard presentation]
Continuity of care in critical care
Naeem Ali (Columbus , United States)
Burden of chronic critical illness
Stephen Trzeciak (Camden , United States)
Long term sequelae of sepsis
Derek C Angus (Pittsburgh , United States)
MRI findings after severe ARDS
Michael Quintel (Göttingen , Germany)
Outcomes of the very elderly
Daren K Heyland (Kingston , Canada)
Recovery from cachexia: Can we learn from athletes?
Paul Wischmeyer (Aurora , United States)
Obesity is an advantage
Peter Pickkers (Nijmegen , Netherlands)
The Chelsea Critical Care Physical Assessment tool (CPAx) to measure functional
recovery
Evelyn Corner (London, United Kingdom)
Acquired dementia following ICU stay
E Wesley Ely (Nashville , United States)
Long-term outcomes: How is it fixable?
Gordon Rubenfeld (Toronto , Canada)
Organ donation [Standard presentation]
End-of-life electrical spikes: Separating fact from fiction
Lakhmir Chawla (Washington , United States)
Management of the potential organ donor
Giuseppe Citerio (Monza , Italy)
Goal-directed resuscitation
John Kellum (Pittsburgh , United States)
Increasing the number of lungs for transplantion
Arthur S Slutsky (Toronto , Canada)
Managing the lung donor
Marco Ranieri (Turin , Italy)
Managing the liver donor
Julia Wendon (London , United Kingdom)
New approaches to clinical trials [Standard presentation]
What multicenter RCTs show a reduced mortality in the critically ill patients?
Giovanni Landoni (Milan, Italy)
Sepsis outcomes: How much is due to the patient, the hospital, or the health system?
Theodore J Iwashyna (Ann Arbor, United States)
New study designs in sepsis
Derek C Angus (Pittsburgh , United States)
We need a core outcome measure set for acute care research (COMET)
John C Marshall (Toronto , Canada)
Cluster RCTs
Rinaldo Bellomo (Melbourne, Australia)
Still struggling with attributable mortality
Jean-François Timsit (Paris, France)
Acute physiological responsiveness: A criterion for trial entry?
Brian Kavanagh (Toronto , Canada)
Acute sepsis MODS vs chronic critical illness
Clifford S Deutschman (Philadelphia , United States)
QALYs as an outcome
Niall Ferguson (Toronto , Canada)
Neurological testing and quality of life
Niklas Nielsen (Helsingborg, Sweden)
ARDS as an end-point
Taylor Thompson (Boston , United States)
To what extent can we use surrogate markers?
Antoni Torres (Barcelona , Spain)
The value of observational studies
James Krinsley (Stamford , United States)
The role of data safety and monitoring boards
Arthur S Slutsky (Toronto , Canada)
Trials and tribulations of pre-hospital CPR trials
Gavin Perkins (Warwick , United Kingdom)
Feasible endpoints for clinical trials
Michael Reade (Herston QLD, Australia)
Guidelines and bundles [Standard presentation]
Medical informatics to guide therapy
Paul Vespa (Los Angeles , United States)
Using apps as a support
Martin Möckel (Berlin, Germany)
AWARE and CERTAIN: Novel intelligence application
Ognjen Gajic (Rochester , United States)
Pros and cons of protocols
Brian Kavanagh (Toronto , Canada)
The NICE experience: Influence of committees and politicians
Max Jonas (Southampton , United Kingdom)
Improving compliance with sepsis guidelines
Niranjan (Tex) Kissoon (Vancouver , Canada)
The hemodynamic recommendations of the Surviving Sepsis Campaign are simply
unacceptable
Azriel Perel (Tel Aviv , Israel)
How come hospitals that care for more sepsis patients may not produce better
outcomes?
Theodore J Iwashyna (Ann Arbor, United States)
Quality improvement through education: The MEDUSA trial
Konrad Reinhart (Jena , Germany)
What about guideline adherence in cardiogenic shock therapy?
Karl Werdan (Halle , Germany)
What would you do when there is little evidence?
Gordon Rubenfeld (Toronto , Canada)
How to improve ICU quality [Standard presentation]
How to select your computer-information management systel
Jean-Daniel Chiche (Paris , France)
A user's guide to quality metrics
Theodore J Iwashyna (Ann Arbor, United States)
Improving quality through benchmarking
Leo Anthony Celi (Cambridge, United States)
Is readmission to the ICU a good quality measure?
Jeremy M Kahn (Pittsburgh , United States)
Regionalization of care
Mitchell Levy (Providence , United States)
How structure, process and organization impact ICU outcomes
Greg S Martin (Atlanta , United States)
ICU staffing [Standard presentation]
Impact of ICU staffing and organization on outcomes
Derek C Angus (Pittsburgh , United States)
Do nighttime intensivists make a difference?
Mitchell Levy (Providence , United States)
Will we all hire advance practice providers in the ICU?
Jeremy M Kahn (Pittsburgh , United States)
ICU telemedicine: Panacea or placebo?
Jeremy M Kahn (Pittsburgh , United States)
Many strategies for cost containment are not cost saving
Gordon Rubenfeld (Toronto , Canada)
Can we still learn from autopsy? [Standard presentation]
Unexpected findings in critically ill patients: The role of autopsy
Giorgio Berlot (Trieste , Italy)
Thanatology scanner: Autopsy today
Eric Maury (Paris , France)
Histological changes associated with organ dysfunction
José Angel Lorente (Madrid , Spain)
Public awareness [Standard presentation]
Communicating about sepsis
Konrad Reinhart (Jena , Germany)
How to talk to the public
Paul E Pepe (Dallas , United States)
Should public reporting be mandatory?
Mitchell Levy (Providence , United States)
Improving rounds in the ICU [Standard presentation]
How to cope with moral distress in the team
Janice L. Zimmerman (Houston , United States)
The 10 rules of successful rounds JL Vincent
Jean-Louis Vincent (Brussels , Belgium)
Inviting the family to join ICU rounds: Folly or the future?
Taylor Thompson (Boston , United States)
Interruptions during ward rounds: Necessary evil or a nuisance
Balasubramanian Venkatesh (Brisbane , Australia)
Rounds by telemedicine?
Paul Vespa (Los Angeles , United States)
Intensive care around the globe [Standard presentation]
A tale of 7 cities
Derek C Angus (Pittsburgh , United States)
Intensive care in Asia
Development of critical care medicine in the Asia-Pacific region
Anthony McLean (Sydney , Australia)
Implementing cheap but effective ICUs in lower income countries
Marcus Schultz (Amsterdam , Netherlands)
Critical care is very cost-effective in developing countries
Ognjen Gajic (Rochester , United States)
The global burden of sepsis
Konrad Reinhart (Jena , Germany)
Sepsis internationally: I am IMPRESSed
Mitchell Levy (Providence , United States)
Surviving sepsis in resource limited environments
Niranjan (Tex) Kissoon (Vancouver , Canada)
There are disparities in critical care in each country
Kenneth Christopher (Boston, United States)
Workforce issues in intensive care: A global perspective
Balasubramanian Venkatesh (Brisbane , Australia)
End-of-life care [Standard presentation]
Diagnosing dying: A new role for intensivists
Ken Hillman (Liverpool , Australia)
We do not know enough about patients’ preferences?
Daren K Heyland (Kingston , Canada)
Antibiotics should be withheld in terminally ill patients
Michael S Niederman (Mineola , United States)
The use of futility is futile
Jan Bakker (Rotterdam , Netherlands)
The prolonged critically ill patient: How to stay motivated
Geert Meyfroidt (Leuven , Belgium)
A hard Canadian experience
Gordon Rubenfeld (Toronto , Canada)
Do we need palliative care specialists?
Michael Quintel (Göttingen , Germany)
Extubation or terminal weaning?
Jean Reignier (La Roche Sur Yon Cedex 9 , France)
Palliative sedation
Steven Laureys (Liège , Belgium)
How to provide a "good death"
E Wesley Ely (Nashville , United States)
Denied ICU admissions [Standard presentation]
New admission policies for cancer patients
Elie Azoulay (Paris , France)
The patient is too old
Bertrand Guidet (Paris , France)
The patient is too frail
Sean Bagshaw (Edmonton , Canada)
Pro/con Fluid loading [Standard presentation]
Fluid administration should be generous
Daniel De Backer (Brussels , Belgium)
Fluid administration should be restricted
Simon Finfer (Sydney , Australia)
Does quantity really matter?
Lauralyn McIntyre (Ottawa , Canada)
Fluid and the kidney [Standard presentation]
The acute hemodynamic effects of furosemide
Rinaldo Bellomo (Melbourne, Australia)
Are diuretics bad for the kidney?
Sean Bagshaw (Edmonton , Canada)
Optimal use of ultrafiltration in fluid overload
Amir Kazory (Gainesville, United States)
Genomic medicine in the ICU: Ready for prime time? [Plenary lecture]
Genomic medicine in the ICU: Ready for prime time?
Andrew Shaw (Durham , United States)
Genome wide associated studiesfor ICU patients [Plenary lecture]
Genome wide associated studies in ICU patients
Jean-Paul Mira (Paris , France)
Diagnosis and management of sepsis in children [Plenary lecture]
Diagnosis and management of sepsis in children
Niranjan (Tex) Kissoon (Vancouver , Canada)
Non-antibiotics approaches for treating severe infections [Plenary lecture]
Non-antibiotic approaches for treating severe infections
Jean Chastre (Paris , France)
Ventilating the massively obese [Plenary lecture]
Ventilating the massively obese patient
John J Marini (St Paul , United States)
Biomarkers should be included in the classification of renal dysfunction [Pro-con
debate]
Biomarkers should be included in the classification of renal dysfunction
PRO :
Michael Darmon (Saint-Priest-en-Jarez, France)
CON : - Michael Joannidis (Innsbruck , Austria)
Albumin is affordable [Pro-con debate]
Albumin is affordable
PRO :
Albert Farrugia (Perth, Australia)
CON : - Jukka Takala (Bern , Switzerland)
Early tracheostomy [Pro-con debate]
Early tracheostomy
PRO :
Marco Ranieri (Turin , Italy)
CON : - Andres Esteban (Madrid , Spain)
HES should not be used outside RCTs [Pro-con debate]
HES should not be used outside RCTs
PRO :
Simon Finfer (Sydney , Australia)
CON : - Monty G Mythen (London , United Kingdom)
Colloids in sepsis [Pro-con debate]
Colloids in sepsis
PRO :
Claude Martin (Marseille , France)
CON : - Konrad Reinhart (Jena , Germany)
Only large scale RCTs can tell what treatments work? [Pro-con debate]
Only large scale RCTs can tell which treatments work?
PRO :
Simon Finfer (Sydney , Australia) - Derek C Angus (Pittsburgh , United States)
CON : - John J Marini (St Paul , United States)
Should we apply the SSC guidelines for hemodynamic resuscitation in septic shock?
[Pro-con debate]
Should we apply the SSC guidelines for hemodynamic resuscitation in septic shock?
PRO :
Mitchell Levy (Providence , United States) - Greg S Martin (Atlanta , United
States)
CON : - Jean-Louis Teboul (Le Kremlin-Bicêtre , France)
ICU admission of cirrhotic patients is futile [Pro-con debate]
ICU admission of cirrhotic patients is futile
PRO :
Pierre-François Laterre (Brussels , Belgium)
CON : - Julia Wendon (London , United Kingdom)
Do you measure CVP? [Pro-con debate]
Do you measure CVP?
PRO :
Daniel De Backer (Brussels , Belgium) - Jean-Louis Teboul (Le Kremlin-
Bicêtre , France)
CON : - Daniel Reuter (Hamburg , Germany)
Blood lactate is a biomarker of hypoperfusion in sepsis [Pro-con debate]
Blood lactate is a biomarker of hypoperfusion in sepsis
PRO :
Jan Bakker (Rotterdam , Netherlands)
CON : - Rinaldo Bellomo (Melbourne, Australia)
Is plateau pressure able to guide ventilation in ARDS? [Pro-con debate]
Is plateau pressure able to guide ventilation in ARDS?
PRO :
John J Marini (St Paul , United States)
CON : - Marco Ranieri (Turin , Italy)
Still a place for the pulmonary artery catheter (RT) [Round table]
Still a place for the pulmonary artery catheter
Daniel De Backer (Brussels , Belgium) - Michael Pinsky (Pittsburgh , United States)
- Jukka Takala (Bern , Switzerland) - Andrew Rhodes (London , United Kingdom)
- Xavier Monnet (Le Kremlin-Bicêtre , France) - John Kellum (Pittsburgh , United
States)
Goal-directed perioperative optimization: My strategy (RT) [Round table]
Moderators : Charles S Brudney (Durham , United States)
Goal-directed perioperative optimization: My strategy
Matthieu Biais (Bordeaux, France) - Simon Davies (York, United Kingdom) - Michael
Sander (Berlin , Germany) - Andreas Hoeft (Bonn , Germany) - Daniel Reuter
(Hamburg , Germany)
Optimal amount of calories and proteins (RT) [Round table]
Moderators : Adam Deane (Adelaide , Australia)
Optimal amount of calories and proteins
Michael Hiesmayr (Vienna , Austria) - Arthur Van Zanten (Ede , Netherlands) - Daren K
Heyland (Kingston , Canada) - Jan Wernerman (Stockholm , Sweden) - Paul
Wischmeyer (Aurora , United States)
Big data in Critical Care [Round table]
Big Data in Critical Care
Jeremy M Kahn (Pittsburgh , United States) - Jean-Louis Vincent (Brussels , Belgium)
- Theodore J Iwashyna (Ann Arbor, United States) - John C Marshall (Toronto , Canada)
- Kenneth Christopher (Boston, United States) - Leo Anthony Celi (Cambridge, United
States) - Djillali Annane (Garches , France)
Balancing between syndromes and diseases (RT) [Round table]
Balancing between syndromes and diseases
Challenging diagnosis-based medicine (RT) [Round table]
Challenging diagnosis-based medicine
Ken Hillman (Liverpool , Australia)
Should we abandon the concept of ARDS and sepsis [Round table]
Should we abandon the concepts of ARDS and sepsis?
Gordon Rubenfeld (Toronto , Canada) - Marco Ranieri (Turin , Italy) - Luciano
Gattinoni (Milan , Italy) - Niall Ferguson (Toronto , Canada) - Clifford S Deutschman
(Philadelphia , United States) - John C Marshall (Toronto , Canada)
Microcirculation-targeted therapy: Are we ready? [Round table]
Microcirculation-targeted therapy: Are we ready?
Jan Bakker (Rotterdam , Netherlands) - Jacques Duranteau (Le Kremlin-Bicêtre , France)
- Can Ince (Amsterdam , Netherlands) - Antonio Messias (Loures, Portugal) - Daniel De
Backer (Brussels , Belgium)
My tips and tricks for enteral nutrition (RT) [Round table]
Moderators : Michael Hiesmayr (Vienna , Austria)
My tips and tricks for enteral nutrition
Stephen McClave (Louisville, United States) - Paul Wischmeyer (Aurora , United States)
- Jean-Charles Preiser (Brussels , Belgium) - Jean Reignier (La Roche Sur Yon Cedex
9 , France) - Adam Deane (Adelaide , Australia)
Statistics for dummies (TU) [Tutorial]
Statistics for dummies
Dominique Benoit (Ghent , Belgium)
Management of severe ARDS (TU) [Tutorial]
Management of severe ARDS
Laurent Brochard (Toronto, Canada)
Innate immunity (TU) [Tutorial]
Innate immunity
Thierry Calandra (Lausanne , Switzerland)
Hematological emergencies (TU) [Tutorial]
Hematological emergencies
Michael Darmon (Saint-Priest-en-Jarez, France)
ECMO (TU) [Tutorial]
ECMO
Alain Combes (Paris , France)
Mechanical ventilation in ARDS (TU) [Tutorial]
Mechanical ventilation in ARDS
Dimitris Georgopoulos (Heraklion , Greece)
Antimicrobial therapy of VAP (TU) [Tutorial]
Antimicrobial therapy of VAP
Jean Chastre (Paris , France)
Necrotizing skin and soft tissue infections (TU) [Tutorial]
Necrotizing skin and soft tissue infections
Jan De Waele (Ghent , Belgium)
Prevention of pulmonary postoperative complications (TU) [Tutorial]
Prevention of pulmonary postoperative complications
Samir Jaber (Montpellier , France)
Plasmapheresis (TU) [Tutorial]
Plasmapheresis
Bertrand Guidet (Paris , France)
Managing end-of-life care in the ICU (TU) [Tutorial]
Managing end-of-life care in the ICU
Ken Hillman (Liverpool , Australia)
Ultrasound for intensivists (TU) [Tutorial]
Ultrasound for intensivists
Eric Maury (Paris , France)
Nutritional support (TU) [Tutorial]
Nutritional support
Daren K Heyland (Kingston , Canada)
Renal replacement therapies (TU) [Tutorial]
Renal replacement therapies
Ravindra Mehta (San Diego , United States)
Medical management of abdominal hypertension (TU) [Tutorial]
Medical management of abdominal hypertension
Manu Malbrain (Antwerp , Belgium)
Metabolic conundrums (TU) [Tutorial]
Metabolic conundrums
Mervyn Singer (London , United Kingdom)
ICP management (TU) [Tutorial]
ICP management
Stephan A Mayer (New York , United States)
Perioperative hemodynamic monitoring and optimization (TU) [Tutorial]
Perioperative hemodynamic monitoring and optimization
Mikhail Kirov (Arkhangelsk , Russia)
How I use hemodynamic monitoring (TU) [Tutorial]
How I use hemodynamic monitoring
Azriel Perel (Tel Aviv , Israel)
Interpretation of SvO2/ScvO2 (TU) [Tutorial]
Interpretation of SvO2/ScvO2
Xavier Monnet (Le Kremlin-Bicêtre , France)
Functional hemodynamic monitoring (TU) [Tutorial]
Functional hemodynamic monitoring
Michael Pinsky (Pittsburgh , United States)
Extracorporeal lung support (TU) [Tutorial]
Extracorporeal lung support
Michael Quintel (Göttingen , Germany)
Polytrauma (Tu) [Tutorial]
Polytrauma
Kjetil Sunde (Oslo , Norway)
Subarachnoid hemorrhage (TU) [Tutorial]
Subarachnoid hemorrhage
Paul Vespa (Los Angeles , United States)
Decompensated COPD (TU) [Tutorial]
Decompensated COPD
Tobias Welte (Hannover , Germany)
Parenteral nutrition in the ICU (TU) [Tutorial]
Parenteral nutrition in the ICU
Paul Wischmeyer (Aurora , United States)
Drugs of abuse (TU) [Tutorial]
Drugs of abuse
Janice L. Zimmerman (Houston , United States)
Metabolic acidosis - an idiots guide (TU) [Tutorial]
Metabolic acidosis: An idiots guide
Monty G Mythen (London , United Kingdom)
Acute myocardial infarction (TU) [Tutorial]
Acute myocardial infarction
Martin Möckel (Berlin, Germany)
Protein metabolism (TU) [Tutorial]
Protein metabolism
Jan Wernerman (Stockholm , Sweden)
Multidrug resistant bacteria (TU) [Tutorial]
Multidrug resistant bacteria
Robert Bonomo (Cleveland, United States)
The various modes of mechanical ventilation (TU) [Tutorial]
The various modes of mechanical ventilation
Robert Chatburn (Cleveland, United States)
Traumatic brain injury (TU) [Tutorial]
Traumatic brain injury
Giuseppe Citerio (Monza , Italy)
Controversies in CPR (TU) [Tutorial]
Controversies in CPR
Jerry Nolan (Bath , United Kingdom)
How I can use microcirculation to target therapy (W) [Workshop]
How I can use the microcirculation to target therapy
Jacques Duranteau (Le Kremlin-Bicêtre , France) - Jan Bakker (Rotterdam , Netherlands)
- Can Ince (Amsterdam , Netherlands) - Didier Payen (Paris , France) - Daniel De
Backer (Brussels , Belgium)
My favoured future therapies in sepsis (W) [Workshop]
My favoured future therapies in sepsis
John C Marshall (Toronto , Canada) - Richard Hotchkiss (St Louis , United States)
- Tom van der Poll (Amsterdam , Netherlands) - Didier Payen (Paris , France) - Steven
Opal (Providence , United States)

Source: https://pfizeracademy.dk/materiale/64/34thpreprogram.pdf

Microsoft word - ng - medical release 2014.doc

Dear Parent or Guardian, Please complete a separate release for each minor that will be participating in church activities. Please print all information. Student Personal Information: Parent/Legal Guardian Information: Insurance Information: Person other than parents to notify in case of emergency: Personal Permission and Medical Information: In the event of an emer

Microsoft word - epr-3 guideline change page.doc

Skip to content past banner and navigation links Guidelines for the Diagnosis and Management of Asthma — Full Report Change Page The EPR-3 was initially posted to the NHLBI website in August 2007. Periodically edits are made to this document and these edits are logged onto this change page. As of August 5, 2008 the following edits have been made (specific wording changes

© 2010-2018 PDF pharmacy articles